ARVN003
ARVN003, known as MicroLine in US, is a pharmacologic treatment for presbyopia developed by Eyenovia, Inc. (NASDAQ: EYEN). Current treatment options for presbyopia are typically device-based, such as reading glasses and contact lenses. Pilocarpine ophthalmic solution is known to constrict the pupil and improve near-distance vision by creating an extended depth of focus through its small aperture effect.
We believe that administration of pilocarpine using the Eyenovia's high precision microdosing technology (MAP™) could provide a meaningful improvement in near vision while enhancing tolerability and usability.
To report a potential adverse event, please refer to the contact information below:
Global: globalsafety@arcticvision.com
Mainland China: safety.cn@arcticvision.com
Hong Kong, China: safety.hk@arcticvision.com